Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.67 |
| ▸ | TP53 | P04637 | 3/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10113952 | 0.87 | CYP1A2 (0.75) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL15384325 | 0.84 | CYP1A2 (0.50) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL15075832 | 0.84 | LMNA (0.51) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL14754389 | 0.83 | CYP1A2 (0.70) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL19036514 | 0.83 | CYP1A2 (0.67) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL19036714 | 0.82 | RXFP1 (0.73) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL19036489 | 0.82 | KMT2A (0.74) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL15075757 | 0.81 | CYP1A2 (0.77) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL15075669 | 0.81 | CYP1A2 (0.67) | CYP1A2RXFP1TP53ALOX15ALDH1A1 | |
| SCHEMBL20079646 | 0.81 | RXFP1 (0.69) | CYP1A2RXFP1TP53ALOX15ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130059869-A1 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS | HYDRA BIOSCIENCES, INC. | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059869-A1 | METHODS AND COMPOSITIONS FOR TREATING DISORDERS | TRPA1, TRPV1, TRPV3 | CYP1A2 1369/4885RXFP1 1374/4885TP53 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.